BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1107790)

  • 1. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hyperkinetic child: current status.
    Dubey DR
    Compr Ther; 1982 May; 8(5):58-67. PubMed ID: 7094561
    [No Abstract]   [Full Text] [Related]  

  • 5. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction.
    Conners CK; Taylor E; Meo G; Kurtz MA; Fournier M
    Psychopharmacologia; 1972; 26(4):321-36. PubMed ID: 4508756
    [No Abstract]   [Full Text] [Related]  

  • 8. Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction.
    Conners CK; Taylor E
    Arch Gen Psychiatry; 1980 Aug; 37(8):922-30. PubMed ID: 7406656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Millichap JG
    Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851
    [No Abstract]   [Full Text] [Related]  

  • 10. MBD: advanced in understanding many bothersome dilemmas.
    Seals JR
    Adv Pediatr; 1976; 23():113-49. PubMed ID: 795279
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth disturbances in hyperkinetic children.
    Greenhill LL; Puig-Antich J; Halpern F; Sachar EJ; Rubinstein B; Chambers W; Fiscina B; Florea J
    Pediatrics; 1980 Jul; 66(1):152-4. PubMed ID: 7402783
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood levels and tolerance to stimulants in ADDH children.
    Swanson JM; Lerner M; Cantwell D
    Clin Neuropharmacol; 1986; 9 Suppl 4():523-5. PubMed ID: 3567959
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
    Wender PH; Wood DR; Reimherr FW
    Psychopharmacol Bull; 1985; 21(2):222-31. PubMed ID: 3923527
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stimulant therapy in children].
    Steinhausen HC
    Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
    [No Abstract]   [Full Text] [Related]  

  • 18. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
    Wender PH
    J Clin Psychiatry; 1998; 59 Suppl 7():76-9. PubMed ID: 9680056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.